Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation Miami Valves 2024

New Cerebral Protection Devices for TAVR

Presenter: Fábio S. Brito Jr.

February 03, 2024

Presentation Interventional Complications 2022

TAVR and Unexplained Hypotension: An Algorithmic Approach

Presenter: Frederick Welt

July 15, 2022

Presentation TCT 2020

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presenter: Michael Megaly

October 15, 2020

Presentation TCT 2020

TCT 227: The Role of Neighborhood Disadvantage in Predicting Mortality in Patients After Transcatheter Aortic Valve Replacement

Presenter: Jesse Goitia

October 14, 2020

Presentation

TAVR in Oncology Patients With Severe AS

January 10, 2019

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

Presentation

Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist TAVR

January 16, 2018

Presentation

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

October 17, 2017

Presentation

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

September 27, 2017

Presentation

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

August 22, 2017

Presentation SOLACI 2017

Clinical Evidence of TAVR in Intermediate Risk Patients: Lessons from Clinical Trials

Presenter: Andreas Baumbach

August 02, 2017

Presentation

Initial Experience of Second-Generation Self-Expandable TAVR System (Evolut R)

February 09, 2017

Presentation

Early Clinical Outcomes with Self-Expandable TAVR System (Evolut R) in Severe AS

Presenter: Jeffrey Popma

February 09, 2017

Presentation TVT 2016

TVT 1176: Compassionate Use of a Self-Expanding Aortic Valve Bioprosthesis in Severe Aortic Regurgitation Without Aortic Stenosis or Annular Calcification

Presenter: Mehul Patel, MD

June 17, 2016

Presentation TVT 2016

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Presenter: Ganesh Manoharan

June 17, 2016

Presentation TVT 2016

TVT 1162: Calcium and the Rising EDP TAVR and Same-Setting PVL Closure

Presenter: Jonathon M. White

June 16, 2016

Presentation

Should TAVR Be Performed in 90-Year-Old Patients?

Presenter: M. Arsalan

March 22, 2016

Presentation

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Presenter: Marco Barbanti

September 21, 2015

Presentation

Comparison of Outcomes of TAVR in Patients Older than 90 Years vs Younger than 90 Years

Presenter: Yigal Abramowitz

July 24, 2015

Presentation

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Presenter: Johan Bosmans

July 14, 2015

Advertisement

New Cerebral Protection Devices for TAVR

TAVR and Unexplained Hypotension: An Algorithmic Approach

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

TCT 227: The Role of Neighborhood Disadvantage in Predicting Mortality in Patients After Transcatheter Aortic Valve Replacement

TAVR in Oncology Patients With Severe AS

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist TAVR

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

Clinical Evidence of TAVR in Intermediate Risk Patients: Lessons from Clinical Trials

Initial Experience of Second-Generation Self-Expandable TAVR System (Evolut R)

Early Clinical Outcomes with Self-Expandable TAVR System (Evolut R) in Severe AS

TVT 1176: Compassionate Use of a Self-Expanding Aortic Valve Bioprosthesis in Severe Aortic Regurgitation Without Aortic Stenosis or Annular Calcification

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

TVT 1162: Calcium and the Rising EDP TAVR and Same-Setting PVL Closure

Should TAVR Be Performed in 90-Year-Old Patients?

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Comparison of Outcomes of TAVR in Patients Older than 90 Years vs Younger than 90 Years

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content